A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelet Counts <50,000/ul).

  • Perkins, Andrew (Primary Chief Investigator (PCI))
  • Ma, Chun Kei Kris (Chief Investigator (CI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date16/03/2131/12/26

Keywords

  • Blood disorders
  • Myelofibrosis
  • clinical trial